MarketingMedicalPolicy,Access,Value, andEvidenceConsultingData,Technology,and Media
murmuration of birds
Previous
Next

company news

Welcoming our new CEO, Jonathan Koch

10/1/2021

Jon brings exceptional experience leading global, customer-centered organizations of scale and is driven to build a sustainable, people-focused future for Avalere Health.

Jonathan Koch has joined Avalere Health as our new CEO tasked with driving a sustainable future for the company. Jon will lead us through our next phase of growth, which is centered on building and retaining talented teams and delivering a full set of integrated services for our clients across the life science industry.

Jon brings exceptional experience leading global, customer-centered organizations of scale and is driven to build a sustainable, people-focused future for Avalere Health. 

“Building a sustainable future for Avalere Health means attracting, developing, and retaining talented team members who are knowledgeable, passionate, and effective, and above all, anchored in our shared purpose and values,” explains Jon. “This, coupled with developing an exceptional integrated service set for our clients, is one of the most important things I can do as a leader. Doing so will ensure our teams are empowered to innovate for our life science clients and the patients and healthcare professionals we all serve.”

While Jon does not shy away from the challenging decisions that need to be made by the CEO, he is a believer in the power of the team, leading and working without hierarchy. He has significant experience in transforming businesses and leading teams and companies of all sizes, including large, global, customer-centered organizations.

Jon has spent his entire career in the healthcare sector and is looking forward to building relationships with our pharma, biotech, and medical technology clients and developing a deep understanding of their goals, needs, and expectations of our business.

He spent 12 years working at Covance (now Labcorp Drug Development), where he last served as Group President of Clinical Development and Commercialization services and led more than 11,000 employees across dozens of countries. Over the last two decades, Jon developed a deep passion for helping life science companies bring innovative therapies to market that positively impact patients’ outcomes.

Most recently, Jon served as Senior Vice President and CEO of Global Dental at the publicly listed organization Henry Schein, where he was responsible for the strategic direction and business performance of its largest healthcare division and leading technology business.

“This is an exciting time for Jon to join our organization,” says Gail Flockhart, Chief Commercial Officer. “We have achieved tremendous growth through extensive client relationships, and our acquisition strategy has successfully brought specialist capabilities together to become a leading commercialization partner for clients. We are looking forward to this new phase in which Jon can share his extensive experience of successfully unifying businesses by improving processes and infrastructure needed for efficient and effective delivery of new integrated services and technologies.”

Jon’s appointment follows the news that Oliver Dennis and Dominic Miller stepped down from their roles as CEO and COO in September 2021. The Avalere Health team greatly respects and appreciates Oliver’s and Dominic’s leadership and personal investment in building the company over the last 20 years and is excited to usher in a new era under Jon’s leadership.

Get in touch

Find out more about Avalere Health’s solutions from advisory to implementation across the product lifecycle.

Contact us

This article was originally published on October 1, 2021.

How we use cookies

Cookies are files saved on your phone, tablet or computer when you visit a website.

We use cookies to store information about how you use the Fishawack Health website, such as the pages you visit.

For more information, check the cookie statement

32E8261E-A569-4B66-ACC6-3CB772DDEDEE

Cookie settings

We use 4 types of cookies. You can choose which cookies you're happy for us to use.

Cookies that measure website use.

We use Google Analytics to measure how you use the website so we can improve it based on user needs. We do not allow Google to use or share the data about how you use this site.

  • how you got to the site
  • the pages you visit on fishawack.com, and how long you spend on each page
  • what you click on while you're visiting the site

Cookies that help with our communications and marketing

These cookies may be set by third party websites and do things like measure how you view Vimeo videos that are on Fishawack.com.

Cookies that remember your settings

These cookies do things like remember your preferences and the choices you make, to personalize your experience of using the site.

Strictly necessary cookies

These essential cookies do things like remember your progress through a form (eg. Registering for new content alerts).

These cookies always need to be on.